Business Description
Gujarat Themis Biosyn Ltd
ISIN : INE942C01045
Total Employee Number:
224Compare
Compare
Traded in other countries / regions
506879.India IPO Date
2025-02-25Description
Gujarat Themis Biosyn Ltd is engaged in manufacturing, exporting, and selling of bulk drugs on a job-work basis. The company operates in one segment which is pharmaceuticals. Its products include Rifamycin-S, which is an intermediate for Rifampicin for the treatment of tuberculosis (TB), and Lovastatin.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.04 | |||||
Equity-to-Asset | 0.57 | |||||
Debt-to-Equity | 0.56 | |||||
Debt-to-EBITDA | 2.08 | |||||
Interest Coverage | 21.23 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 11.97 | |||||
Beneish M-Score | -2.09 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.8 | |||||
3-Year EBITDA Growth Rate | -0.9 | |||||
3-Year EPS without NRI Growth Rate | -7 | |||||
3-Year Book Growth Rate | 24.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 32.01 | |||||
9-Day RSI | 37.7 | |||||
14-Day RSI | 42.46 | |||||
3-1 Month Momentum % | 19.05 | |||||
6-1 Month Momentum % | 6.58 | |||||
12-1 Month Momentum % | 2.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.12 | |||||
Quick Ratio | 0.93 | |||||
Cash Ratio | 0.08 | |||||
Days Inventory | 122.11 | |||||
Days Sales Outstanding | 93.4 | |||||
Days Payable | 357.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.18 | |||||
Dividend Payout Ratio | 0.16 | |||||
3-Year Dividend Growth Rate | -15.7 | |||||
Forward Dividend Yield % | 0.18 | |||||
5-Year Yield-on-Cost % | 0.3 | |||||
Shareholder Yield % | -2.3 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 83.37 | |||||
Operating Margin % | 37.76 | |||||
Net Margin % | 28.15 | |||||
EBITDA Margin % | 47.01 | |||||
FCF Margin % | -74.63 | |||||
OCF Margin % | 29.42 | |||||
ROE % | 17.49 | |||||
ROA % | 11.85 | |||||
ROIC % | 13.2 | |||||
3-Year ROIIC % | -2.29 | |||||
ROC (Joel Greenblatt) % | 19.21 | |||||
ROCE % | 18.68 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 86.24 | |||||
PE Ratio without NRI | 86.24 | |||||
Shiller PE Ratio | 109.16 | |||||
PEG Ratio | 8.45 | |||||
PS Ratio | 24.28 | |||||
PB Ratio | 13.98 | |||||
Price-to-Tangible-Book | 13.98 | |||||
Price-to-Operating-Cash-Flow | 82.54 | |||||
EV-to-EBIT | 64.23 | |||||
EV-to-EBITDA | 53.58 | |||||
EV-to-Revenue | 25.19 | |||||
EV-to-FCF | -33.75 | |||||
Price-to-GF-Value | 1.18 | |||||
Price-to-DCF (Earnings Based) | 3.62 | |||||
Price-to-Median-PS-Value | 5.77 | |||||
Price-to-Peter-Lynch-Fair-Value | 12.15 | |||||
Price-to-Graham-Number | 7.32 | |||||
Earnings Yield (Greenblatt) % | 1.56 | |||||
FCF Yield % | -3.08 | |||||
Forward Rate of Return (Yacktman) % | 9.74 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Gujarat Themis Biosyn Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 1,658.228 | ||
| EPS (TTM) (₹) | 4.28 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 79.48 | ||
| 14-Day RSI | 42.46 | ||
| 14-Day ATR (₹) | 15.220883 | ||
| 20-Day SMA (₹) | 384.92 | ||
| 12-1 Month Momentum % | 2.32 | ||
| 52-Week Range (₹) | 225.05 - 479 | ||
| Shares Outstanding (Mil) | 108.97 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Gujarat Themis Biosyn Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Gujarat Themis Biosyn Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| INR 0.670000 Cash Dividend | 2025-09-04 | 393.40 (+4.77%) |
Show
Entries
Gujarat Themis Biosyn Ltd Frequently Asked Questions
What is Gujarat Themis Biosyn Ltd(NSE:GUJTHEM)'s stock price today?
The current price of NSE:GUJTHEM is ₹369.60. The 52 week high of NSE:GUJTHEM is ₹479.00 and 52 week low is ₹225.05.
When is next earnings date of Gujarat Themis Biosyn Ltd(NSE:GUJTHEM)?
The next earnings date of Gujarat Themis Biosyn Ltd(NSE:GUJTHEM) is .
Does Gujarat Themis Biosyn Ltd(NSE:GUJTHEM) pay dividends? If so, how much?
The Dividend Yield %  of Gujarat Themis Biosyn Ltd(NSE:GUJTHEM) is 0.18% (As of Today), Highest Dividend Payout Ratio of Gujarat Themis Biosyn Ltd(NSE:GUJTHEM) was 0.21. The lowest was 0.04. And the median was 0.1. The  Forward Dividend Yield % of Gujarat Themis Biosyn Ltd(NSE:GUJTHEM) is 0.18%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Gujarat Themis Biosyn Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers